Article Sidebar
Keywords:
Cirrhosis, hepatitis delta, pegylated interferon, therapy
How to Cite
KABAÇAM, G., DALEKOS, G. N., ÇAKALOĞLU, Y., ZACHOU, K., BOCK, T., ERHARDT, A., … Yurdaydın, C. (2012). Pegylated interferon-based treatment in patients with advanced liver disease due to chronic delta hepatitis. Turkish Journal of Gastroenterology, 23(5), 560–568. https://doi.org/10.4318/tjg.2012.0538
Main Article Content
Gökhan KABAÇAM
Department of Gastroenterology, Ankara Lokman Hekim Hospital, Ankara
George N. DALEKOS
Department of Internal Medicine, University of Thessaly Medical School, Larisa, Greece
Yılmaz ÇAKALOĞLU
Department of Gastroenterohepatology, University of İstanbul Medical School, İstanbul
Kalliopi ZACHOU
Department of Internal Medicine, University of Thessaly Medical School, Larisa, Greece
Thomas BOCK
Department of Molecular Pathology, Institute of Pathology, University of Tuebingen, Tuebingen, Germany
Andreas ERHARDT
Department of Gastroenterology, University of Düsseldorf, Düsseldorf, Germany
Stefan ZEUZEM
Department of Gastroenterology, University of Düsseldorf, Düsseldorf, Germany
Fehmi TABAK
İstanbul Üniversitesi Cerrahpaşa Tıp Fakültesi İç Hastalıkları, Kardiyoloji, Patoloji Anabilim Dalları, İstanbul
Kendal YALÇIN
Department of Gastroenterology, University of Dicle School of Medicine, Diyarbakır
A. Mithat Bozdayı
Institute of Hepatology, Ankara University Faculty of Medicine, Ankara, Turkey
Hans P. DIENES
University of Cologne, Institute of Pathology, Cologne, Germany
Hakan BOZKAYA
Department of Gastroenterology, University of Ankara Medical School, Ankara
Michael MANNS
Department of Gastroenterology, Hepatology and Endocrinology, University of Hannover Medical School, Hannover, Germany
Heiner WEDEMEYER
Department of Gastroenterology, Hepatology and Endocrinology, University of Hannover Medical School, Hannover, Germany
Cihan Yurdaydın
Institute of Hepatology, Ankara University Faculty of Medicine, Ankara, Turkey; Department of Gastroenterology, Ankara University Faculty of Medicine, Ankara, Turkey.
Pegylated interferon-based treatment in patients with advanced liver disease due to chronic delta hepatitis
Main Article Content
Gökhan KABAÇAM
Department of Gastroenterology, Ankara Lokman Hekim Hospital, Ankara
George N. DALEKOS
Department of Internal Medicine, University of Thessaly Medical School, Larisa, Greece
Yılmaz ÇAKALOĞLU
Department of Gastroenterohepatology, University of İstanbul Medical School, İstanbul
Kalliopi ZACHOU
Department of Internal Medicine, University of Thessaly Medical School, Larisa, Greece
Thomas BOCK
Department of Molecular Pathology, Institute of Pathology, University of Tuebingen, Tuebingen, Germany
Andreas ERHARDT
Department of Gastroenterology, University of Düsseldorf, Düsseldorf, Germany
Stefan ZEUZEM
Department of Gastroenterology, University of Düsseldorf, Düsseldorf, Germany
Fehmi TABAK
İstanbul Üniversitesi Cerrahpaşa Tıp Fakültesi İç Hastalıkları, Kardiyoloji, Patoloji Anabilim Dalları, İstanbul
Kendal YALÇIN
Department of Gastroenterology, University of Dicle School of Medicine, Diyarbakır
A. Mithat Bozdayı
Institute of Hepatology, Ankara University Faculty of Medicine, Ankara, Turkey
Hans P. DIENES
University of Cologne, Institute of Pathology, Cologne, Germany
Hakan BOZKAYA
Department of Gastroenterology, University of Ankara Medical School, Ankara
Michael MANNS
Department of Gastroenterology, Hepatology and Endocrinology, University of Hannover Medical School, Hannover, Germany
Heiner WEDEMEYER
Department of Gastroenterology, Hepatology and Endocrinology, University of Hannover Medical School, Hannover, Germany
Cihan Yurdaydın
Institute of Hepatology, Ankara University Faculty of Medicine, Ankara, Turkey; Department of Gastroenterology, Ankara University Faculty of Medicine, Ankara, Turkey.